Multiple studies by Barthelemey et al. and groups have studied tau phosphorylation in CSF, brain, and plasma and reported an association between site-specific changes in tau phosphorylation and evolution of stages of dominantly inherited Alzheimer’s disease [48,49,50]. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.